PHAXIAM Therapeutics S.A.
Stock Forecast, Prediction & Price Target
PHAXIAM Therapeutics S.A. Financial Estimates
PHAXIAM Therapeutics S.A. Revenue Estimates
PHAXIAM Therapeutics S.A. EBITDA Estimates
PHAXIAM Therapeutics S.A. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
Net Income
% change YoY
| $-73.3M N/A | $-53.79M 26.60% | $-227K 99.57% | Avg: $-18.91M Low: $-37.69M High: $-37.69M avg. -8232.67% | Avg: $-19.37M Low: $0 High: $0 avg. -2.41% | ||
EBITDA
% change YoY
| $-67.94M N/A | $-47.45M 30.15% | $-22.69M 52.17% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
EPS
% change YoY
| -$3.99 N/A | -$2.27 43.10% | -$0.01 99.67% | Avg: -$1.22 Low: -$1.22 High: -$1.22 avg. -16548.21% | Avg: $0 Low: $0 High: $0 avg. 100% | ||
Operating Expenses
% change YoY
| $68.83M N/A | $56.51M -17.89% | $27.14M -51.96% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | ||
FAQ
What is PHAXIAM Therapeutics S.A. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -4117.54% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -37.69M, average is -18.91M and high is -37.69M.
What is PHAXIAM Therapeutics S.A. stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is PHAXIAM Therapeutics S.A. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -8274.10% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.22, average is -$1.22 and high is $-1.21.